KALEIDO BIOSCIENCES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • February 19th, 2019 • Kaleido Biosciences, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (“Agreement”) is made as of January 24, 2019, between Kaleido Biosciences, Inc., a Delaware corporation (the “Company”), and Joshua Brumm (the “Employee”) and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”).
KALEIDO BIOSCIENCES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • February 19th, 2019 • Kaleido Biosciences, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (“Agreement”) is made as of January 24, 2019, between Kaleido Biosciences, Inc., a Delaware corporation (the “Company”), and Katharine Knobil (the “Employee”) and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”).
CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF...Umbrella Development Services Agreement • February 19th, 2019 • Kaleido Biosciences, Inc. • Biological products, (no disgnostic substances) • Delaware
The following services are out of scope for this Master Agreement and would require additional terms to be agreed by the parties:
